GGenetics Read More Congruence secures $32m in funds for genetic obesity drug trialSeptember 5, 2025 The funds are earmarked to advance the trial of the genetic obesity drug CGX-926. Credit: MGARCIA_CREATIVE / Shutterstock.com.…